Balloon in the womb may ease lung pressure in severe birth defect

NCT ID NCT03980717

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study tests a procedure called FETO, where a tiny balloon is placed in the fetus's windpipe to help the lungs grow. It focuses on babies with severe congenital diaphragmatic hernia (CDH), a condition where abdominal organs move into the chest and stunt lung development. Researchers want to see if FETO helps resolve pulmonary hypertension (high blood pressure in the lungs) by age 1. The study will compare 40 babies who get FETO with 40 who do not.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
Goldbal detachable balloon device (FETO)
What this could lead to
If successful, FETO could become a standard way to improve lung development and reduce dangerous lung blood pressure in babies with severe CDH, potentially increasing survival.
What could go wrong
This is a small, early-stage prospective study (80 participants) comparing outcomes to a non-randomized control group. The procedure carries risks of preterm labor or balloon-related complications, and benefits are not yet proven.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CONGENITAL DIAPHRAGMATIC HERNIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Texas Childrens Hospital

    RECRUITING

    Houston, Texas, 77030, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.